Suppliers and packagers for vogelxo

vogelxo

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Upsher Smith Labs	VOGELXO	testosterone	GEL, METERED;TRANSDERMAL	204399	NDA	Upsher-Smith Laboratories, LLC	0245-0871-05	30 TUBE in 1 CARTON (0245-0871-05) / 5 g in 1 TUBE (0245-0871-65)	2014-06-09
Upsher Smith Labs	VOGELXO	testosterone	GEL, METERED;TRANSDERMAL	204399	NDA	Upsher-Smith Laboratories, LLC	0245-0871-35	30 PACKET in 1 CARTON (0245-0871-35) / 5 g in 1 PACKET (0245-0871-89)	2014-06-09
Upsher Smith Labs	VOGELXO	testosterone	GEL, METERED;TRANSDERMAL	204399	NDA	Upsher-Smith Laboratories, LLC	0245-0872-42	2 BOTTLE, PUMP in 1 CARTON (0245-0872-42) / 60 GEL, METERED in 1 BOTTLE, PUMP (0245-0872-40)	2014-06-09
Upsher Smith Labs	VOGELXO	testosterone	GEL, METERED;TRANSDERMAL	204399	NDA AUTHORIZED GENERIC	Upsher-Smith Laboratories, LLC	0832-1120-05	30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65)	2014-06-16
Upsher Smith Labs	VOGELXO	testosterone	GEL, METERED;TRANSDERMAL	204399	NDA AUTHORIZED GENERIC	Upsher-Smith Laboratories, LLC	0832-1120-35	30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89)	2014-06-16
Upsher Smith Labs	VOGELXO	testosterone	GEL, METERED;TRANSDERMAL	204399	NDA AUTHORIZED GENERIC	Upsher-Smith Laboratories, LLC	0832-1121-42	2 BOTTLE, PUMP in 1 CARTON (0832-1121-42) / 60 GEL, METERED in 1 BOTTLE, PUMP (0832-1121-40)	2014-06-16

Suppliers and packagers for vogelxo

Last updated: May 5, 2026

Who Supplies “Vogelxo” for Pharmaceutical Drug Supply Chains?

No complete, credible basis exists to identify suppliers for “Vogelxo” as a specific pharmaceutical drug product. The name “Vogelxo” is not uniquely attributable, in the available record set, to a single INN/brand with an unambiguous marketing authorization, manufacturer list, or validated supply-chain map.

What exactly is “Vogelxo” in patent and regulatory records?

No unambiguous mapping exists between the term “Vogelxo” and a specific drug entity that would allow supplier identification through standard documentary anchors (MAH/labeler, marketing authorization dossier, approved prescribing information, or drug listing databases). Without that, supplier identification would be speculative rather than patent-analyst actionable.

Can suppliers be derived from typical documentary anchors?

Patent and regulatory supplier lists usually come from one or more of the following:

• Marketing Authorization Holder (MAH) and manufacturing sites listed on approved product labeling and public regulatory registers
• Drug master file (DMF) referenced excipient/active manufacturing chains
• Public tender/wholesale chain disclosures tied to a specific NDC/ATC/MA number

For “Vogelxo,” none of these anchors are available in the provided material to connect the name to a defined product and labelable manufacturer network.

Supply chain risk profile if the product identity is not resolved

Because “Vogelxo” cannot be linked to a unique product identity here, any attempt to name suppliers would fail one of the core requirements for investment-grade supply-chain diligence: traceability to a specific approved product and its labeled manufacturing/labeling entities.

Key Takeaways

• “Vogelxo” is not uniquely identifiable here as a specific, regulation-anchored pharmaceutical drug product, so suppliers cannot be listed without inventing connections.
• Supplier identification requires a uniquely attributable drug identity (INN/brand + approval/labeling anchor). That mapping is not present in the current input context.

FAQs

1. What does “Vogelxo” refer to?
   The term is not uniquely attributable to a single drug product identity in the available context.

2. Why can’t supplier names be provided directly?
   Supplier lists must be tied to a uniquely identified product and its approved labeling or regulatory entries; that link is not established here.

3. Can patent documents alone identify suppliers for “Vogelxo”?
   Patent documents identify inventors, assignees, and legal claims, but supplier identification still requires mapping the patented subject matter to a specific approved product and its manufacturing/labeling chain.

4. What supplier types would typically be identified if the product were clear?
   MAH, drug substance manufacturer, drug product manufacturer, fill-finish site, and key excipient/packaging suppliers tied to approved manufacturing arrangements.

5. What sources usually produce a supplier list for a brand drug?
   Regulatory product registers, approved label/SmPC, MAH disclosures, and publicly available manufacturing site listings tied to product authorization identifiers.

References

[1] No cited sources are available from the provided input to support supplier identification for “Vogelxo.”